Science of the treatment of diseases of the female sexual organs and reproductive tract
POPULARITY
Categories
Second and/or Third trimester vaginal bleeding is a common reason for L&D Triage patient assessment. The evaluation starts with determining the status of maternal hemodynamic stability. This together with IV access are key first steps. This is followed by an assessment of fetal-placental status. Typically this includes bedside ultrasound for fetal position, visual confirmation of FHTs, amniotic fluid determination, and placental location. At the same time, lab data is obtained to guide care: CBC, fibrinogen, type and RH, and possibly type and cross. Do you order a KB test as part of the STANDRAD evaluation for suspected placental abruption? In this episode, we will review a new study released ahead of print on June 8, 2025 in the European J of Obstetrics, Gynecology, and Repro Biology. Listen in for details.
A new podcast from Obstetrics & Gynecology, featuring members from the Editorial Team and contributing authors, each month as they highlight the latest research and practice updates in the field. This episode features an interview with Drs. Sue Li and Nilam S. Mangalmurti, authors of “Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.”
It's been nearly three years since the Dobbs decision, which the Supreme Court used to strip women of the right to control our own bodies. In that decision—and frequently presented across the ideological spectrum as an alternative to abortion—adoption has been at the forefront of the discussion. But is adoption as benevolent and empowering as it is presented to be?Our guest today argues that it is not—and she's got compelling evidence to back that up. Dr. Gretchen Sisson is a researcher at Advancing New Standards in Reproductive Health in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. Her book Relinquished: The Politics of Adoption and the Privilege of American Motherhood received a starred review from Publisher's Weekly and much more acclaim.
Join current F&S editors Drs. Micah Hill, Kurt Barnhart, and Allison Eubanks in an engaging discussion with past Editors-in-Chief, Drs. Alan DeCherney, Craig Niederberger, and Antonio Pellicer! View Fertility and Sterility at https://www.fertstert.org/
If you've been feeling like your energy has vanished overnight, you're not alone! But what if I told you it isn't due to stress or aging, or even hormones—it's all happening deep inside your cells? In this episode, I'm joined by the brilliant Dr. Felice Gersh to explore the powerful connection between hormone shifts and your mitochondria—the tiny engines that fuel every cell in your body. We'll uncover why fatigue, brain fog, and stubborn weight gain aren't “just signs of aging”, but signals your body is craving cellular support. Dr. Gersh breaks down how perimenopause and menopause can disrupt your mitochondrial function—and most importantly, what you can do right now to turn things around. From lifestyle tweaks to science-backed strategies, this episode is full of insights to help you restore your vitality from the inside out. Tune in here and uncover Dr. Gersh's tips to rebuild your energy, balance your hormones, and step into a new season of life with power and confidence! Felice Gersh, M.D. Dr. Felice Gersh is a multi-award-winning OB-GYN with dual board certifications in Obstetrics & Gynecology and Integrative Medicine. She's the founder and director of the Integrative Medical Group of Irvine, and is the brilliant mind behind the bestselling PCOS SOS series and her newest book, Menopause: 50 Things You Need to Know. She speaks globally on women's health, and she's regularly published in peer-reviewed medical journals. IN THIS EPISODE What it means to have good cellular health in menopause Addressing the knowledge gap in women's health care What's happening at a cellular level with hormonal changes Optimizing mitochondrial function for longevity Lifestyle factors that impact cellular aging in women The latest research on NAD and how it supports energy The future of cellular health science and how it can empower women to live longer, fuller lives QUOTES “Healthy longevity means lowering systemic inflammation, and our vital life hormones– estradiol and progesterone– are really critical for that.” “When you have unhealthy mitochondria, or dying, damaged mitochondria, the effects are not just that you make less energy, which is huge, but you also don't control the cell cycle.” “If you wanna live that beautiful, high-vitality, high-energized life in your 70s, 80s, and beyond…you talked about not even having issues until you're in your mid-90s– then we absolutely have to be proactive.” RESOURCES MENTIONED Menopause SOS: Your FREE mini menopause survival guide! Get my personal discount on Qualia Senolytic cell rejuvination regimen with code ENERGIZED >>> Integrative Medical Group of Irvine Dr. Gersh on YouTube Dr. Gersh's Socials: Instagram Facebook LinkedIn RELATED EPISODES 640: Unveiling The Essential Role of Minerals For Cellular Energy And Detoxification with Caroline Alan #623: Red Light Therapy for Upgrading Your Mitochondria, Cellular Energy, Skin and Brain Health with Jonathan Otto #551: How to Know if You Have a Sluggish Metabolism and How It Impacts Your Weight, Hormones, and Cellular Energy #330: Why Mitochondria Are the Key to Unlocking Your Best Energy Yet with Shawn Wells
Expert Approach to Hereditary Gastrointestinal Cancers presented by CGA-IGC
This episode is hosted by Emma Keel, MS, CGC, and features Ying Liu, MD, MPH, a Gynecologic Medical Oncologist & Clinical Geneticist, Memorial Sloan Kettering Cancer Center, and Nicole D. Edison, MD, Clinical Associate of Obstetrics & Gynecology, University of Chicago.The in-depth discussion focuses on managing gynecologic cancer risk in patients with Lynch syndrome, spotlighting the significant updates to the National Comprehensive Cancer Network (NCCN) guidelines released in September 2024 that have shifted the clinical approach for these patients.
In this episode of Health Matters, we discuss what causes dizziness with Dr. Louise Klebanoff, a neurologist with NewYork-Presbyterian and Weill Cornell Medicine. Dr. Klebanoff explains the different types of dizziness, such as lightheadedness, vertigo, and gait instability. We also cover how to differentiate between these types, the potential causes, and when to seek medical attention.___Dr. Louise Klebanoff, MD has been named the Chief of General Neurology and the Vice Chair of Operations for the Department of Neurology at Weill Cornell Medical College. She is also an Assistant Attending Neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Klebanoff received her medical degree from Georgetown University Medical Center, graduating first in her class, and went on to complete a residency in Neurology and a fellowship in Critical Care Neurology at NewYork-Presbyterian Hospital/Columbia University Medical Center.Prior to joining the Weill Cornell faculty, Dr. Klebanoff served as Attending Neurologist at Beth Israel Medical Center, where she also held leadership roles on various committees and served as the first female president of the Medical Board.Dr. Klebanoff is board certified in Psychiatry and Neurology. She is a member of the Alpha Omega Alpha honor society, the American Medical Association and the American Academy of Neurology.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org
Amanda Kallen is an associate professor in the Division of Reproductive Endocrinology and Infertility at the University of Vermont Larner College of Medicine and an adjunct professor at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.N. Kallen and Others. Undermining Women's Health Research — Gambling with the Public's Health. N Engl J Med 2025;392:2185-2187.
Dave and Tyler get excited for some LEGO builds coming to a mall near you. Tyler is frustrated by deductibles and Dave is happy he doesn't have a vagina.Get the VIDEO VERSION of the Podcast HERE!!!! @TylerCarrfm@Energy106fmTyler Carr on Tik Tok
June is Men's Health Month, and we want to bring attention to male infertility. Why this is an important health topic is one of the questions we ask our expert for this episode, Samuel Prien, Ph.D., professor and director of clinical research laboratories in the Department of Obstetrics and Gynecology in the School of Medicine. Dr. Prien explains what factors contribute to male fertility and infertility, what is considered a healthy sperm count and what lifestyle factors could affect sperm health. He encourages us to talk about this topic more openly so couples thinking about conceiving might possibly save time and money by first checking the male's fertility.
In this episode, Dr. Carolyn Moyers breaks down the latest original research from the April 2025 issue of Obstetrics & Gynecology, focusing on the long-term cardiovascular biomarker changes in women who participated in the Women's Health Initiative Hormone Therapy Trials. What does this mean for real-life patients considering hormone therapy? Are there age-related risks? What's the deal with triglycerides?Dr. Moyers explores the clinical relevance of these findings, limitations of the data, and the questions that still remain—offering an evidence-based, patient-centered perspective for women navigating menopause and their heart health.
Take a sneak peek at this month's Fertility & Sterility! Articles discussed this month are: 02:17 Effects of preimplantation genetic testing for aneuploidy on embryo transfer outcomes in women of advanced reproductive age with no more than three retrieved oocytes 15:30 Using National IVF Registries to Validate Clinical Outcomes Following IVF Covered by Health Insurance 29:38 Impact of corpus luteum number on maternal pregnancy and birth outcomes: the Rotterdam Periconception Cohort 39:15 Systematic review and Meta-analysis of the impact of the re-freezing and re-biopsy embryos on reproductive outcomes in patients undergoing freeze-thaw embryo transfer 50:20 A blastocyst's implantation potential is linked to its originating oocyte cohort's blastulation rate: evidence for a cohort effect 01:02:56 Linzagolix rapidly reduces heavy menstrual bleeding in women with uterine fibroids: An analysis of the PRIMROSE 1 & 2 trials View Fertility and Sterility at https://www.fertstert.org/
Episode 193: Gestational Diabetes IntroJesica Mendoza (OMSIII) describes the pathophysiology of gestational diabetes and the right timing and method of screening for it. Dr. Arreaza adds insight into the need for culturally-appropriate foods, such as vegetables in Mexican cuisine. Written by Jesica Mendoza, OMSIII, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. Editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.DefinitionGestational diabetes mellitus (GDM) is a condition that occurs to previously non-diabetic pregnant women, caused by glucose intolerance at around the 24th week of gestation. PathophysiologyGDM arises due to an underlying pancreatic beta cell dysfunction in the mother which leads to a decrease in the amount of insulin produced and thus leads to higher blood sugar levels during pregnancy. The placenta of the fetus will produce hPL (human placental lactogen) to ensure a steady supply of sugars to the fetus, creating an anti-insulin effect. However, hPL readily crosses the placental barrier causing the mothers insulin requirement to increase, when the mother's pancreas cannot increase production of insulin to that level needed to counter the effect of hPL they become diabetic, and this leads to gestational diabetes. So, basically the placenta is asking for more glucose for the baby and the mother's pancreas struggles to keep the glucose level within normal limits in the body of the mother. If left untreated, high levels of glucose in the mother can cause glucotoxicity in the mother.“Glucotoxicity” refers to the toxic effect of glucose. Glucose is the main fuel for cell functions, but when it is high in the bloodstream, it causes toxicity to organs. Prevalence of GDM.The CDC reports mean prevenance of GDM is 6.9%. In U.S. mothers the prevenance increased from 6.0% in 2016 to 8.3% in 2021. Many different factors have played a role in increasing gestational diabetes in American mothers, some of those being the ongoing obesity epidemic with excess body weight being a known risk factor for insulin resistance. Another being advanced maternal age (AMA) as more American women have children later in life their body becomes less sensitive to insulin and requires a higher insulin output on top of the insulin that is required for the fetus. The “American diet” is also something that has a big effect in diabetes development. With the increase of high-carb foods that are readily available, the diet of Americans has declined and is affecting the metabolic health of mothers as they carry and deliver their children. Despite ongoing awareness of GDM, 6% to 9% of pregnant women in the United States are diagnosed with gestational diabetes, and the prevalence continues to increase worldwide. It is estimated that in 2017 18.4 million pregnancies were affected by GDM in the world, which then continued to increase to 1 in 6 births to women with GDM in 2019. It was also found that women living in low-income communities were disproportionately affected due to limited healthcare access. Additionally, women with GDM had a 1.4-fold increase in likelihood of undergoing a c-section, with 15% increase in risk of requiring blood transfusion. Screening for GDMGestational diabetes is screened between the 24th to 28th week of gestation in all women without known pregestational diabetes. In women who have high-risk for GDM the screening occurs during the first trimester, these women usually have at least one of the following: BMI > 30, prior history of GDM, known impaired glucose metabolism, and/or a strong family history of diabetes. The screening during the first trimester is to detect “pregestational diabetes” because we have to keep a good glycemic control to improve outcomes of pregnancy. So, if it's positive, you start treatment immediately. If these women are found to have a normal glucose, they repeat the testing again as done normally, at 24-28 weeks of gestation. How do we screen?The screening itself consists of two types of approaches. The two-step approach includes a 50-gram oral glucose tolerance test (OGTT), where blood glucose is measured in an hour and if it is below 140 they are considered to not have GDM, however if the reading is greater than 140 they must then do a 3-hour, 100g oral glucose tolerance test. The 3-hour OGTT includes measuring the blood sugars at Fasting which should be less than 95, at 1 hour at less than 180, at 2 hours at less than 155, and at 3 hours at less than 140. If 2 or more of these values exceed the threshold the patient is diagnosed with gestational diabetes mellitus. The one-step approach includes 75g after an overnight fast. Blood glucose is measured while fasting which should be less than 92, at 1 hour less than 180 and at 2 hours less than 153. If any one of these values is exceeded, the patient is diagnosed with GDM.If the mother is found to be GDM positive during pregnancy she will also need continued screening post-partum to monitor for any development of overt diabetes. The testing is usually 75g 2-hour OGTT at 6-12 weeks postpartum. If this testing is normal, then they are tested using HbA1c every 3 years. If the post-partum testing shows pre-diabetes, annual testing is recommended using HbA1c measurements. Maternal complications Women with GDM are at an increased risk for future cardiovascular disease, T2DM, and chronic kidney disease. GDM is also associated with increased likelihood of developing pre-eclampsia following delivery. Pre-eclampsia is a complication seen in pregnancy characterized by high blood pressure, proteinuria, vision changes, and liver involvement (high LFTs). Pre-eclampsia can then progress to eclampsia or HELLP syndrome, both of which can include end organ damage. Additionally, she can develop polyhydramnios which leads to overstretching of the uterus and can induce pre-term labor, placental abruption, and or uterine atony, all of which additionally put the mother at increased risk for c-section. All of these maternal complications that stem from GDM lead to complications and extended hospitalization. Child's complications Although there is an increased set of risks for the mother, the neonate can also develop a variety of risks due to the increased glucose while in utero. While the fetus is growing, the placenta is the source of nutrition for the fetus. As the levels of glucose in the mother increase so does the amount of glucose filtered through the placenta and into the fetal circulation. Over time the glucose leads to oxidative stress and inflammation with activation of TGF-b which leads to fibroblast activation and fibrosis of the placenta. This fibrosis decreases the nutrient and oxygen exchange for the fetus. As the fetus attempts to grow in this restrictive environment its development is affected. The fetus can develop IUGR (intrauterine growth restriction) leading to a small for gestation age newborn which can then lead to another set of complications. The low oxygen environment can lead to increased EPO production and polycythemia at birth which can then lead to increased clotting that can travel to the newborn brain. Newborns can also be born with fetal acidosis due to the anerobic metabolism and lactic acid buildup in fetal tissues which can cause fetal encephalopathy leading to cerebral palsy and developmental delay. And the most severe of newborn complications to gestational diabetes can lead to fetal demise. Furthermore, the increase of glucose can also lead to macrosomia in the infant which can often lead to a traumatic delivery and delivery complications such as shoulder dystocia and brachial plexus injury. Brachial plexus injury sometimes resolves without sequela, but other times can lead to permanent weakness or paralysis of the affected arm. The baby can be born too small or too big.Additionally, once the fetus is born the cutting of the umbilical cord leads to a rapid deceleration in blood glucose in the fetal circulation and hypoglycemic episodes can occur, that often lead to NICU admission. The insulin that is created by the fetus in utero to accommodate the large quantities of glucose is known to affect lung maturation as well. The insulin produced inhibits surfactant production in the fetus. Upon birth some of the newborns also have to be placed on PEEP for ventilation and some children require treatment with surfactant to prevent alveolar collapse and/or progression to NRDS created by the low surfactant levels. Additionally, neonates who are macrosomic, which is usually seen in GDM mothers, are larger and stronger and when put on PEEP to help increase ventilation the newborn's stronger respiratory effort can lead to higher pulmonary pressures and barotrauma such as neonatal pneumothorax.Long term complications to the child of a mother with GDM also occur. As the child grows, they are also at an increased risk for developing early onset obesity because of the increased adipose storage triggered by the increase in insulin in response to the high glucose in utero. This then can lead to a higher chance of developing type 2 diabetes mellitus in the child. With diabetes, also comes an increase in cardiovascular risk as the child ages and becomes an adult. The effects of GDM go beyond the fetal life but continue through adulthood.What can be done?Gestational Diabetes Mellitus has many severe and lifelong consequences for both the mother and the child and prevention of GDM would help enhance the quality of life of both. Many of the ways to prevent GDM complications include patient education and dietary modifications with a diet rich in whole grains, fruits, vegetables and lean proteins. Benefits of some vegetables in the Mexican cuisine that may be beneficial: Nopales, Chayote, and Jicama. Those are good alternatives for highly processed carbs.Mothers are usually offered nutritional counseling to help them develop a tailored eating plan. This and 30 minutes of moderate exercise daily is recommended to increase insulin sensitivity and lower the post-prandial glucose levels. If within 2 weeks of implementing lifestyle changes alone the glucose measurements remain high, then medications like insulin can be put onboard to manage the GDM. If they require insulin, I think it is time to refer to a higher level of care, if available, high risk OB clinic.Conclusion: Now we conclude episode number ###, “[TITLE].” [summary here]. _____________________References:Eades CE, Burrows KA, Andreeva R, Stansfield DR, Evans JM. Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Mar 15;24(1):204. doi: 10.1186/s12884-024-06378-2. PMID: 38491497; PMCID: PMC10941381. https://pubmed.ncbi.nlm.nih.gov/38491497/QuickStats: Percentage of Mothers with Gestational Diabetes,* by Maternal Age — National Vital Statistics System, United States, 2016 and 2021. Weekly / January 6, 2023 / 72(1);16. https://www.cdc.gov/mmwr/volumes/72/wr/mm7201a4.htm?utmAkinyemi OA, Weldeslase TA, Odusanya E, Akueme NT, Omokhodion OV, Fasokun ME, Makanjuola D, Fakorede M, Ogundipe T. Profiles and Outcomes of Women with Gestational Diabetes Mellitus in the United States. Cureus. 2023 Jul 4;15(7):e41360. doi: 10.7759/cureus.41360. PMID: 37546039; PMCID: PMC10399637. https://pmc.ncbi.nlm.nih.gov/articles/PMC10399637/?utmPerlman, J. M. (2006). Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics, 117(3), S28–S33.DOI: 10.1542/peds.2005-0620C.Low, J. A. (1997). Intrapartum fetal asphyxia: definition, diagnosis, and classification. American Journal of Obstetrics and Gynecology, 176(5), 957–959.DOI: 10.1016/S0002-9378(97)70609-0.Hallman, M., Gluck, L., & Liggins, G. (1985). Role of insulin in delaying surfactant production in the fetal lung. Journal of Pediatrics, 106(5), 786–790.DOI: 10.1016/S0022-3476(85)80227-0.Sweet, D. G., Carnielli, V., Greisen, G., et al. (2019). European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update. Neonatology, 115(4), 432–450.DOI: 10.1159/000499361.Raju, T. N. K., et al. (1999). Respiratory distress in term infants: when to suspect surfactant deficiency. Pediatrics, 103(5), 903–909.DOI: 10.1542/peds.103.5.903.Burns, C. M., Rutherford, M. A., Boardman, J. P., & Cowan, F. M. (2008). Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics, 122(1), 65–74.DOI: 10.1542/peds.2007-2822.Dabelea, D., et al. (2000). Long-term impact of maternal diabetes on obesity in childhood. Diabetes Care, 23(10), 1534–1540.DOI: 10.2337/diacare.23.10.1534.Dashe, J. S., et al. (2002). "Hydramnios: Etiology and outcome." Obstetrics & Gynecology, 100(5 Pt 1), 957–962.DOI: 10.1016/S0029-7844(02)02279-6.Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to prevent gestational diabetes mellitus: a decision-analytic modelling study. Diabetologia.American College of Obstetricians and Gynecologists. (2018). Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstetrics & Gynecology, 131(2), e49–e64. https://doi.org/10.1097/AOG.0000000000002501Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.
On this episode of the Take Good Care podcast, Drs. Williams, Guthrie, and Greene continue their discussion on who Rosa Gynecology is. They dive deeper into the actions and activities they have done as business owners and physicians that support who they think Rosa Gynecology is and what Rosa Gynecology believes.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP In addition to heavy menstrual bleeding, patients with uterine fibroids often deal with many other considerable effects on their physical and mental wellbeing. To provide optimal care, it's important to recognize the full impact of fibroids, communicate carefully about treatment options, and promote equitable access to care. Dr. Charles Turck sits down with Dr. Ayman Al-Hendy to learn more about how we can address the multifaceted burden of uterine fibroids. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.
Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Guest(s): Elizabeth Lutz, M.D., Associate Professor of Medicine in the Department of Obstetrics and Gynecology at UMMC.Topic: Pregnancy planning and possible complicationsEmail the show any time remedy@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Despite longstanding reliance on surgery, recent advancements have reshaped our approach to uterine fibroids. However, common myths and misconceptions have limited the adoption of newer therapies, leaving many patients unaware of their available options. Join Dr. Charles Turck and Dr. Ayman Al-Hendy as they explain shifting treatment paradigms and patient education strategies in uterine fibroid care. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.
In this episode, Dr. Shawn Tassone discusses the importance of pap smears in women's health, addressing recent misinformation and the historical context of cervical cancer screening. He emphasizes the significance of regular screenings, the role of HPV, and the process of pap smears, while debunking myths propagated by health influencers. Dr. Tassone advocates for informed health choices and the necessity of understanding the medical procedures that can prevent cervical cancer. Episode Highlights: Pap smears and cervical cancer prevention Misinformation about pap smears How cervical cancer rates have significantly decreased due to screening The history of the pap smear HPV and cervical health Why regular screenings are important The pap smear process Understanding results from pap smears Health influencers and the spread of dangerous misinformation Episode Resources: Dr. Shawn Tassone's Practice | https://www.drshawntassone.com Dr. Shawn Tassone's Book | The Hormone Balance Bible Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormone Archetype Quiz Thank you to our sponsor, Purality Health! The question isn't which supplements to take—it's whether your body can absorb them. Most traditional supplements fall victim to stomach acid before delivering benefits. Purality Health's micelle liposomal technology creates a double-layer protective system that shields nutrients from stomach acid destruction while facilitating direct bloodstream absorption—making supplements up to 800% more effective. For perimenopausal and menopausal patients, I recommend their Vitamin D3 with K2 for bone density and mood regulation, and their exceptional magnesium formula for sleep and muscle tension. As a physician, I value their commitment to quality: cGMP-compliant facilities, purity testing, and organic, non-GMO ingredients without unnecessary fillers. Visit puralityhealth.com/drshawn and use code DRSHAWN for exclusive savings. Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.
Drs. Amy Crockett (@amyhcrockett), Ben Ereshefsky (@brainofbpharm), and Pamela Bailey (@pamipenem) join Dr. Julie Ann Justo (@julie_justo) to discuss new treatment strategies for management of intraamniotic infections, also known as chorioamnionitis. They discuss whether it is time to move away from the combination of ampicillin, gentamicin, and/or clindamycin, alternative antibiotic regimens to consider, and stewardship strategies to approach this practice change at a local level. References: Basic stats/epi on chorioamnionitis: Romero R, et al. Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med. 2015 Jan;43(1):19-36. doi: 10.1515/jpm-2014-0249. PMID: 25720095. ACOG 2017 Guideline for IAI: Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. Obstet Gynecol. 2017 Aug;130(2):e95-e101. doi: 10.1097/AOG.0000000000002236. PMID: 28742677. ACOG 2024 Update on clinical criteria for IAI: ACOG Clinical Practice Update: Update on Criteria for Suspected Diagnosis of Intraamniotic Infection. Obstetrics & Gynecology 144(1):p e17-e19, July 2024. doi: 10.1097/AOG.0000000000005593 Helpful review with more recent microorganisms : Jung E, et al. Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment. Am J Obstet Gynecol. 2024 Mar;230(3S):S807-S840. doi: 10.1016/j.ajog.2023.02.002. PMID: 38233317. Cochrane Review: Chapman E, et al. Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev. 2014 Dec 19;2014(12):CD010976. doi: 10.1002/14651858.CD010976.pub2. PMID: 25526426. Helpful recent review on intrapartum infections: Bailey, P, et al_._ Out with the Old, In with the New: A Review of the Treatment of Intrapartum Infections. Curr Infect Dis Rep. 2024;26:107–113 doi: 10.1007/s11908-024-00838-8. Role of genital mycoplasmas in IAI: Romero R, et al. Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study. J Perinat Med. 2019 Nov 26;47(9):915-931. doi: 10.1515/jpm-2019-0297. PMID: 31693497. Regimens without enterococcal coverage with similar clinical outcomes: Blanco JD, et al. Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections. Antimicrob Agents Chemother. 1983 Oct;24(4):500-4. doi: 10.1128/AAC.24.4.500. PMID: 6360038. Bookstaver PB, et al. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015 Nov;35(11):1052-62. doi: 10.1002/phar.1649. PMID: 26598097. Updated review in pregnancy, includes data on frequency of antibiotic use in pregnancy: Nguyen J, et al. A review of antibiotic safety in pregnancy-2025 update. Pharmacotherapy. 2025 Apr;45(4):227-237. doi: 10.1002/phar.70010. Epub 2025 Mar 19. PMID: 40105039. Locksmith GJ, et al. High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels. Obstet Gynecol. 2005 Mar;105(3):473-9. doi: 10.1097/01.AOG.0000151106.87930.1a. PMID: 15738010. Clindamycin CDI Risk: Miller AC, et al. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case-Control Study. Open Forum Infect Dis. 2023 Aug 5;10(8):ofad413. doi: 10.1093/ofid/ofad413. PMID: 37622034. Impact of penicillin allergy on clindamycin use & cites 47% clindamycin resistance per CDC among GBS: Snider JB, et al. Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes. BMC Pregnancy Childbirth. 2023 May 30;23(1):400. doi: 10.1186/s12884-023-05697-0. PMID: 37254067. Clindamycin anaerobic coverage data: Hastey CJ, et al. Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology. Anaerobe. 2016 Dec;42:27-30. doi: 10.1016/j.anaerobe.2016.07.003. PMID: 27427465. Older PK study of ampicillin & gentamicin for chorioamnionitis: Gilstrap LC 3rd, Bawdon RE, Burris J. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis. Obstet Gynecol. 1988 Jul;72(1):124-5. PMID: 3380500. Paper putting out the call for modernization of OB/Gyn antibiotic regimens: Pek Z, Heil E, Wilson E. Getting With the Times: A Review of Peripartum Infections and Proposed Modernized Treatment Regimens. Open Forum Infect Dis. 2022 Sep 5;9(9):ofac460. doi: 10.1093/ofid/ofac460. PMID: 36168554. Vanderbilt University Medical Center experience with modernizing OB/Gyn infection regimens: Smiley C, et al. Implementing Updated Intraamniotic Infection Guidelines at a Large Academic Medical Center. Open Forum Infect Dis. 2024 Sep 5;11(9):ofae475. doi: 10.1093/ofid/ofae475. PMID: 39252868. Prisma Health/University of South Carolina experience with modernizing OB/Gyn infection regimens: Bailey P, et al. Cefoxitin for Intra-amniotic Infections and Endometritis: A Retrospective Comparison to Traditional Antimicrobial Therapy Regimens Within a Healthcare System. Clin Infect Dis. 2024 Jul 19;79(1):247-254. doi: 10.1093/cid/ciae042. PMID: 38297884.
Dr. James A. Thorp is a board-certified obstetrician-gynecologist and maternal-fetal medicine specialist with over 44 years of clinical experience. A U.S. veteran and widely published physician, he has testified internationally, served as a journal peer reviewer, Board Member of the Society for Maternal-Fetal Medicine, and Examiner for the American Board of Obstetrics and Gynecology. He is the author of “Sacrifice: How the Deadliest Vaccine in History Targeted the Most Vulnerable.” Dr. Thorp also serves as the Chief of Maternal Medicine and Prenatal Medicine for the Wellness Company. Follow Dr. James A. Thorp on X: @jathorpmfm VISIT: https://drjamesthorp.com/ & https://abrg.org ORDER: https://sacrifice2024.com/
On this episode of the #TakeGoodCare podcast, Drs. Williams, Guthrie, and Greene continue the discussion on going from chaos to calm. They specifically discuss their workplace, "what" their business is, and more.
In 2014, the International Society for the Study of Women's Sexual Health together with the North American Menopause Society introduced the term “Genitourinary syndrome of menopause” to replace the prior term vulvovaginal atrophy. Ten years after that, in 2024, a related term “Genitourinary Syndrome of LACTATION, was introduced to better capture the genitourinary issues lactating women may experience. A new systematic review, soon to be released in the journal obstetrics and gynecology, provides new data on GSL prevalence and characteristics. This is a good reminder for any clinician who evaluates postpartum/lactating women to ask about GSL. How does sexual dysfunction fit into this question? Listen in to the next episode of Dr. Chapa's Clinical Pearls Podcast for more details.
In this episode of Health Matters, Dr. Mary Rosser, a gynecologist at NewYork-Presbyterian and Columbia, explains perimenopause, breaking down what symptoms are normal, when it's time to see a doctor, and the best options for managing some of the more challenging symptoms of perimenopause. ___Dr. Mary L. Rosser, M.D., Ph.D., NCMP is the Director of Integrated Women's Health at NewYork-Presbyterian/Columbia University Irving Medical Center and the Richard U. and Ellen J. Levine Assistant Professor of Women's Health (in Obstetrics and Gynecology) at Columbia University Vagelos College of Physicians & Surgeons. She joined the faculty of Obstetrics and Gynecology at Columbia University in April 2018 to provide routine gynecology care and to further develop a comprehensive well-woman program. She has been a practicing obstetrician gynecologist for more than 20 years, starting in private practice and then joining the faculty at Montefiore Medical Center in Bronx, NY. While at Montefiore, she created, launched, and led the forty-person Division of General Obstetrics and Gynecology. Dr. Rosser received her undergraduate degree at Emory University and a Ph.D. in Endocrinology at the Medical College of Georgia. She attended Wake Forest University School of Medicine and completed her residency at Emory University. She is also a NAMS Certified Menopause Practitioner, able to provide high-quality care for patients at menopause and beyond.Primary care and heart disease in women have always been areas of focus for Dr. Rosser. She conducted basic science research on heart disease during graduate school and was the Chair of the "Women & Heart Disease Physician Education Initiative" for District II of the American College of Obstetrics & Gynecology. She continues to conduct clinical studies around patient awareness and understanding of heart disease and well-woman care. Dr. Rosser serves on the Medical Leadership Team of the Go Red for Women movement of the American Heart Association and she is ACOG's liaison to the American College of Cardiology.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org
Alice Rothchild's path to becoming an anti-Zionist Jew took many years, many hard conversations, and required a lot of critical self-reflection. But she is part of a growing, powerful chorus of Jewish voices around the world speaking out against Israel's Occupation of Palestine and ethnic cleansing of Palestinians—and she is urging others to join that chorus. “The time is long overdue for liberal Zionists to find the courage to take a long hard look at their uncritical support for the actions of the Israeli state as it becomes increasingly indefensible and destabilizing, a pariah state that has lost its claim to be a so-called democracy (however flawed) that is endangering Jews in the country and abroad as well as Palestinians everywhere,” Rothchild writes in Common Dreams. In the latest installment of The Marc Steiner Show's ongoing series “Not in Our Name,” Marc speaks with Rothchild about her path to anti-Zionism, the endgame of Israel's genocidal assault on Gaza, and the need to liberate Jewish identity from the Zionist state of Israel.Alice Rothchild is a physician, author, and filmmaker with an interest in human rights and social justice. She practiced ob-gyn for almost 40 years and served as Assistant Professor of Obstetrics and Gynecology at Harvard Medical School. She is the author of numerous books, including: Broken Promises, Broken Dreams: Stories of Jewish and Palestinian Trauma and Resilience; Condition Critical: Life and Death in Israel/Palestine; Old Enough to Know, a 2024 Arab American Book Award winner; and Inspired and Outraged: The Making of a Feminist Physician. Rothchild is a member of the Jewish Voice for Peace Health Advisory Council and a mentor-liaison for We Are Not Numbers.Producer: Rosette SewaliStudio Production: David HebdenAudio Post-Production: Alina NehlichHelp us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast
Topics covered in this episode: What is the pelvic floor? Why toilet posture is at the root of pelvic floor dysfunction. The guarding reflex, bladder and bowel dysfunction. Why real or perceived stress impacts your bowel and bladder dysfunction. How big a problem is pelvic floor dysfunction? And more ... Dr. Fleischmann is board certified in urology and Female Pelvic Medicine and Reconstructive Surgery. She received her medical degree from the State University of New York Downstate Health Sciences University in Brooklyn, NY, where she graduated summa cum laude. Dr. Fleischmann completed her surgery and urology residency at Albert Einstein College of Medicine in Bronx, NY and continued her training in a fellowship at NYU School of Medicine. She is passionate about practicing an integrative approach to urogynecology, correcting the pervasive, unconscious and paradoxical behaviors which can turn into the structural problems and bothersome symptoms that prompt women to seek care. She is the author of the new book “The Second Mouth”, which addresses the powerful mind-body connection in functional urology. Dr. Fleischmann serves as Director of FPMRS at White Plains Hospital Center where she has been in clinical practice for the last 25 years. She holds an active appointment as Assistant Clinical Professor in Obstetrics and Assistant Clinical Professor of Gynecology and Urology at Albert Einstein College of Medicine. Additionally, she is a member of the American Urologic Association and Society for Urodynamics and Female Urology (SUFU). Dr. Fleischmann is the author of several research publications and presentations. She lives and practices in New York. @drnicolefleischmann Thesecondmouthbook.com
Alice Rothchild's path to becoming an anti-Zionist Jew took many years, many hard conversations, and required a lot of critical self-reflection. But she is part of a growing, powerful chorus of Jewish voices around the world speaking out against Israel's Occupation of Palestine and ethnic cleansing of Palestinians—and she is urging others to join that chorus. “The time is long overdue for liberal Zionists to find the courage to take a long hard look at their uncritical support for the actions of the Israeli state as it becomes increasingly indefensible and destabilizing, a pariah state that has lost its claim to be a so-called democracy (however flawed) that is endangering Jews in the country and abroad as well as Palestinians everywhere,” Rothchild writes in Common Dreams. In the latest installment of The Marc Steiner Show's ongoing series “Not in Our Name,” Marc speaks with Rothchild about her path to anti-Zionism, the endgame of Israel's genocidal assault on Gaza, and the need to liberate Jewish identity from the Zionist state of Israel.Alice Rothchild is a physician, author, and filmmaker with an interest in human rights and social justice. She practiced ob-gyn for almost 40 years and served as Assistant Professor of Obstetrics and Gynecology at Harvard Medical School. She is the author of numerous books, including: Broken Promises, Broken Dreams: Stories of Jewish and Palestinian Trauma and Resilience; Condition Critical: Life and Death in Israel/Palestine; Old Enough to Know, a 2024 Arab American Book Award winner; and Inspired and Outraged: The Making of a Feminist Physician. Rothchild is a member of the Jewish Voice for Peace Health Advisory Council and a mentor-liaison for We Are Not Numbers.Producer: Rosette SewaliStudio Production: David HebdenAudio Post-Production: Alina NehlichHelp us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast
Endometriosis is a prevalent gynecologic condition that affects approximately 10–15% of women of reproductive age worldwide. For endometriosis related pelvic pain, continuous combination birth control pills have long been the first-line pharmacologic intervention of choice. But new data published May 15, 2025 (ahead of print) in Obstetrics and Gynecology is challenging that tradition. In this episode , we will summarize the key findings of this brand new network systematic review and metanalysis. Plus, we will also review what is missing from the ACOG PB 114 regarding the management of endometriosis. Listen in for details.
Dr. Bruce Dorr MD, URPS, FACOG is boarded in Obstetrics and Gynecology and subspecialty boarded in Female Pelvic Medicine and Reconstructive Surgery and is also a senior medical advisor for Biote. For the last decade he has directed his practice towards a functional medicine practice of hormone health and wellness. We discuss enhancing your hormone health to live happier, healthier, for longer. You can find out more about Bruce's work over at https://www.biote.com Fill out the quick form here: https://forms.gle/AH1tusHRXkC3N5yM6 and be in with the chance of winning an Amazon Gift card Join the FREE Facebook group for The Michael Brian Show at https://www.facebook.com/groups/themichaelbrianshow Follow Mike on Facebook Instagram & Twitter
Women make up half the population in Canada yet there are still major gaps in women's health research. Experts say investments addressing this gap could add years to life and boost the global economy. The Agenda invites Carmen Wyton, Chair and Founder of Women's Health Coalition of Canada; Dr. Amanda Black, Professor of, Obstetrics and Gynecology at The University of Ottawa; and Christine Faubert, Vice President of Health Equity & Mission Impact, at the Heart and Stroke Foundation of Canada to discuss.See omnystudio.com/listener for privacy information.
Original Air Date: May 31st, 2024Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Guest(s): Ashley Anthony, Nurse Practitioner in the Department of Gynecology and Division of Urogynecology at UMMC.Topic: Pelvic floor disorders and treatment optionsEmail the show any time remedy@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.
If you've ever been told "just relax" while in vulvovaginal pain, you're not alone—and you're definitely not crazy. This conversation is about the silent epidemic women keep getting dismissed over.This episode hit me hard. Not because the stories were shocking—but because they weren't. Dr. Chailee Moss joined me to talk about the groundbreaking study she co-authored, recently published in JAMA, that finally puts numbers to the gaslighting so many of our patients experience.We dug into what dismissal looks like in a medical setting and how phrases like "have a glass of wine" or "your exam is normal" can cause lasting harm. For patients living with vulvovaginal pain, being told it's "all in your head" is not just invalidating—it can delay care, destroy trust, and lead people to give up entirely.Dr. Moss shared how her own experiences as a patient shaped her path as a physician. We also talked about the deep-rooted system issues in training and documentation that continue to reinforce doubt instead of compassion. The problem isn't just one bad doctor. It's a medical culture that doesn't know how to listen to women in pain.This isn't just about statistics. It's about rebuilding the broken parts of medicine so more women feel seen, heard, and actually treated. If you've felt dismissed by the system or know someone who has, this episode is for you.sHighlights:Why patients with vulvovaginal pain are often told to "just relax".The power of naming gaslighting and measuring it in clinical care.How medical training creates blind spots around pain and gender.The importance of early diagnosis to prevent years of unnecessary suffering.Resources and organizations helping patients find the right care.If this episode resonated with you, please subscribe, leave a review, and share it with someone who needs to hear it. Let's keep pushing for better care.Dr. Moss's Bio: Dr. Chailee Moss is a gynecologist specializing in vulvovaginal disorders in Washington, D.C. She first became interested in vulvovaginal disorders at the University of North Carolina at Chapel Hill where she earned an M.D. in 2013. She engaged in research on pain and gynecologic surgery during residency training in Ob/Gyn at The Ohio State University where she was a chief of resident education and earned awards for her research and clinical care. Upon graduation, Dr Moss joined the faculty at Johns Hopkins University where she continued to research pain and publish original research in this and other areas. Dr. Moss is board certified by the American Board of Obstetrics and Gynecology and has been an active member of the Society for Academic Specialists in OB/GYN, serving on the research committee and paper award committee. In her free time she enjoys cooking, camping, and travel with her husband and their three energetic children in Baltimore, MD.Resources:BookJama ArticleTight LippedDr. Rahman with Tight LippedIsswsh The National Vulvodynia AssociationGet in Touch with Dr....
Send us a text Think about a community issue that's important to you. It could be a public health issue, it could be a matter of safety in your community, it could even be the overall happiness of your community. When it comes to donating towards those causes, there are three different ways you can tackle the same problem: research, services, or advocacy.In today's episode, let's talk about what it means to tackle an issue from those three different angles and why you might pick one or the other.Links from today's episode:Unmet Menstrual Hygiene Needs Among Low-Income Women | Obstetrics and Gynecology | 2019https://pubmed.ncbi.nlm.nih.gov/30633137/ ICYMI another episode you might enjoy:Episode#141 The Five Sources of Power that Every Shareholder Has (recorded before the 2024 rebranding of this show)Love the book recos on this show? Check out the Progressive Pockets Bookshelf:https://bookshop.org/shop/progressivepockets As an affiliate of Bookshop.org, Progressive Pockets will earn a commission if you make a purchase.Connect With Genet “GG” Gimja:Website https://www.progressivepockets.comTwitter https://twitter.com/prgrssvpckts Work With Me:Email progressivepockets@gmail.com for brand partnerships, business inquiries, and speaking engagements.Easy Ways to Support the Show1. Send this episode to someone you know! Word of mouth is how podcasts grow!2. Buy me a coffee (or a soundproof panel!) https://buymeacoffee.com/progressivepockets 3. Leave a 5 star rating and review for the show!//NO AI TRAINING: Any use of this podcast episode transcript or associated show notes or blog posts to “train” generative artificial intelligence (AI) technologies to generate text is expressly prohibited. This includes, without limitation, technologies that are capable of generating works in the same style or genre as this content. The author reserves all rights to license uses of this work for generative AI training and development of machine learning language models// Support the show
YOUR BIRTH, GOD’S WAY - Christian Pregnancy, Natural Birth, Postpartum, Breastfeeding Help
SHOW NOTES: Many women who want to labor naturally want to know if waterbirth is a safe option for them. I thought I had dealt with this topic in the past, but apparently I hadn't so today I'm doing that while covering this systemic review from the American Journal of Obstetrics and Gynecology. In this episode you will learn: Is water birth safe? What is water birth? Who is a good candidate to have a waterbirth? Who is not a good candidate to have a waterbirth?? Link to article - https://www.ajog.org/article/S0002-9378(23)00604-X/fulltext Helpful Links: — BIBLE STUDY - FREE Bible Study Course - How To Be Sure Of Your Salvation - https://the-ruffled-mango-school.teachable.com/p/how-to-be-sure-of-your-salvation -- COACHING - If you're tired of shallow, cheap, meaningless connections in pregnancy that leave you feeling passed over and confused, The REAL DEAL Transformative Coaching might be for you. If you're ready to invest in coaching that will bring REAL results and REAL change, not only now but for the future of your family and your children's families, let's talk about how this 1-on-1 coaching might be just what you've been looking for! Go here to learn more - https://go.yourbirthgodsway.com/coachinginterest — CHRISTIAN CHILDBIRTH EDUCATION - Sign up HERE for the Your Birth, God's Way Online Christian Childbirth Course! This is a COMPLETE childbirth education course with a God-led foundation taught by a certified nurse-midwife with over 20 years of experience in all sides of the maternity world! - https://go.yourbirthgodsway.com/cec — HOME BIRTH PREP - Having a home birth and need help getting prepared? Sign up HERE for the Home Birth Prep Course. — homebirthprep.com — GET HEALTHY - Sign up here to be the first to know about the new Women's Wellness Program coming from Lori SOON! https://go.yourbirthgodsway.com/yourhealth — MERCH - Get Christian pregnancy and birth merch HERE - https://go.yourbirthgodsway.com/store — RESOURCES & LINKS - All of Lori's Recommended Resources HERE - https://go.yourbirthgodsway.com/resources Sign up for email updates Here Be heard! Take My Quick SURVEY to give input on future episodes you want to hear -- https://bit.ly/yourbirthsurvey Got questions? Email lori@yourbirthgodsway.com Social Media Links: Follow Your Birth, God's Way on Instagram! @yourbirth_godsway Follow the Your Birth, God's Way Facebook Page! facebook.com/lorimorriscnm Join Our Exclusive Online Birth Community -- facebook.com/groups/yourbirthgodsway Learn more about Lori and the podcast at go.yourbirthgodsway.com! DISCLAIMER: Remember that though I am a midwife, I am not YOUR midwife. Nothing in this podcast shall; be construed as medical advice. Listening to this podcast does not mean that we have entered into a patient-care provider relationship. While I strive to provide the most accurate information I can, content is not guaranteed to be 100% accurate. You must do your research and consult other reputable sources, including your provider, to make the best decision for your own care. Talk with your own care provider before putting any information here into practice. Weigh all risks and benefits for yourself knowing that no outcome can be guaranteed. I do not know the specific details about your situation and thus I am not responsible for the outcomes of your choices. Some links may be affiliate links which provide me a small commission when you purchase through them. This does not cost you anything at all and it allows me to continue providing you with the content you love.
Take a sneak peak at this month's Fertility & Sterility! Articles discussed this month are: 4:08 Classification system of human ovarian follicle morphology: recommendations of the National Institute of Child Health and Human Development - sponsored ovarian nomenclature workshop 12:32 Impact of Prednisone on Vasectomy Reversal Outcomes (iPRED Study): Results from a Randomized, Controlled Clinical Trial 21:38 Triggering oocyte maturation in IVF treatment in normal responders: a systematic review and network meta-analysis 33:57 Parental Balanced Translocation Carriers do not have Decreased Usable Blastulation Rates or Live Birth Rates Compared to Infertile Controls 45:28 A re-look at the relevance of TSH and thyroid autoimmunity for pregnancy outcomes: Analyses of RCT data from PPCOS II and AMIGOS View Fertility and Sterility May 2025, Volume 123, Issue 5: https://www.fertstert.org/issue/S0015-0282(25)X0004-2 View Fertility and Sterility at https://www.fertstert.org/
The DOJ is investigating top medical journals for biased editorial practices, alleging they suppressed studies on COVID-19 vaccine risks and alternative therapeutics for partisan reasons. NBC reports the science publications (including CHEST, New England Journal of Medicine, and Obstetrics and Gynecology) were sent letters “questioning their editorial practices.” In response, medical journal The Lancet called the letters “harassment” and claimed science in the USA was being “violently dismembered” by all of these annoying questions being asked by the peasants. “This corrupt web of suppression, fraud, and retractions demands a legal reckoning,” writes epidemiologist Nicolas Hulscher. Dr. Ram Yogendra, MD, MHP, is a board-certified anesthesiologist with a public health background. He advocates for vaccine injury research, highlighting issues like the persistence of S1 spike protein in monocytes post-COVID-19 vaccination. More at https://x.com/dryostradamus and https://covidlonghaulers.com Elijah Schaffer is a journalist for The Gateway Pundit and the host of Slightly Offensive on Censored.TV. He's also a news presenter on Vigilant News Network. Schaffer filmed the Kyle Rittenhouse shootings, was inside the Capitol on January 6, 2021, and went undercover in groups like Antifa and BLM during the 2020 riots. More at https://x.com/ElijahSchaffer 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at https://drdrew.com/sponsors • FRESH PRESSED OLIVE OIL – Olive oil packs the most flavor and healthiest nutrients when it's fresh. Don't settle for stale supermarket olive oils – get it direct from small, award-winning farms! Get your free $39 bottle for just $1 shipping & taste the difference at https://GetFreshDrDrew.com/ • ACTIVE SKIN REPAIR - Repair skin faster with more of the molecule your body creates naturally! Hypochlorous (HOCl) is produced by white blood cells to support healing – and no sting. Get 20% off at https://drdrew.com/skinrepair • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of Talking Away The Taboo, Estie Rose, MS, CGC, Heather Hipp, MD, and Gail Heyman, join Aimee Baron, MD for the second episode of our 5-part IWSTHAB x JSCREEN Podcast series is all about Fragile X. When people think of genetic testing before pregnancy, they often think of Tay-Sachs or cystic fibrosis—but Fragile X is just as important and far less understood. In this episode, Estie Rose and Dr. Heather Hipp explain the difference between recessive and X-linked conditions, what it means to be a Fragile X carrier, and how it can affect fertility and family planning. We also hear from Gail Heyman, who shares her deeply personal journey navigating Fragile X in her own family—and how that led her to advocacy. Whether you're building your family or supporting someone who is, this episode is filled with insight, honesty, and heart. -Click here to watch Part 1: Introduction to Genetics and Infertility More about Estie: Estie Rose is a certified genetic counselor at jscreen. She has a special interest in community education and serves as a resource for individuals who are facing genetic health issues. Connect with Estie: -Follow her on Instagram More about Heather: Dr. Heather Hipp is a Reproductive Endocrinology and Infertility (REI) physician and an Associate Professor at Emory University School of Medicine. She earned her undergraduate degree at Duke University and then her MD degree at Emory University, where she continued her training in residency and fellowship. She is the Program Director for the REI fellowship at Emory and serves as chair for the American Society for Reproductive Medicine Education Committee. Her profession memberships include American College of Obstetrics and Gynecology, American Society for Reproductive Medicine, Alpha Omega Alpha Honor Society, and American Gynecological & Obstetrical Society. She is also on the National Fragile X Foundation Scientific and Clinical Advisory Committee. Her research focuses on women who are carriers for the fragile X mutation and their risk of premature ovarian insufficiency, as well as trends and outcomes of in-vitro fertilization (IVF) in the United States. More about Gail: Gail Heyman is a passionate advocate and leader in the Fragile X community. After her son was diagnosed in 1989, she co-founded the Fragile X Association of Georgia and has served as its director ever since. Her family's experience—spanning three generations affected by Fragile X conditions—fuels her tireless work to raise awareness, promote research, and support others navigating similar challenges. Gail also serves on JScreen's advisory board and has received national recognition for her leadership in genetic advocacy and inclusion. -Click here to learn more about Gail's story -Check out Carly Heyman's book, My eXtra Special Brother -Learn more about Fragile X here Connect with JScreen: -Visit their website -Coupon Code: IWSTHAB18 for $18 off initial testing (no expiration date on this offer) -Follow JScreen on Instagram Connect with us: -Check out our Website - Follow us on Instagram and send us a message -Watch our TikToks -Follow us on Facebook -Watch us on YouTube
When women think about the benefits of menopausal hormone therapy, things like hot flashes, insomnia and vaginal dryness come to mind. But for many women, bone health is, or should be, at the top of the list. In this episode, I speak with Dr. Risa Kagan about the role of estrogen, progesterone, and testosterone in bone health. Definition of Low Bone Mass (Osteopenia) and Osteoporosis The Difference Between a T score and a Z score FRAX- Fracture Risk Assessment Tool When Bone Mass Peaks How to Maximize Bone Health Before Menopause Hits Role of Estrogen in Young Women The Danger Zone- When Most Women Lose the Majority of Their Bone Mass The Role of Birth Control Pills and Prevention of Bone Loss If Exercise is Enough The Relationship Between Hot Flashes and Osteoporosis Bone Loss Post Menopause Impact of Menopausal Estrogen Therapy on Bones Taking Menopausal Hormone Therapy (MHT) in the Absence of Hot Flashes to Protect Bones The Difference Between Bone Density and Bone Quality When it is Appropriate to Take an Anabolic Agent If the TYPE of Estrogen you take matters (Conjugated, Synthetic, Bioidentical) What DOSE of Estrogen is Needed to Prevent Fractures If it is Appropriate to Monitor Estradiol Blood Levels When Taking Transdermal MHT The Target Estradiol Level for Bone Health What Happens to Bone Density When MHT is Discontinued If MHT Should Be Taken Forever If Progestogens Plays a Role in Bone Health The Role of Bazodoxifene (Duovee™) in Bone Health The Role of TESTOSTERONE therapy in Bone Health Another Podcast with Dr. Kagan: When Progesterone is a Problem Dr. Risa Kagan is a Clinical Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California San Francisco, and a consulting gynecologist with Sutter Health. Dr. Kagan has published over 100 scientific papers on post menopause bone health and hormone therapy. Dr. Streicher is on SUBSTACK DrStreicher.Substack.com Articles Monthly newsletter All COME AGAIN podcast episodes Monthly News Flash Reports on recent research Monthly Zoom Ask Me Anything Webinar Information on Dr. Streicher's COME AGAIN Podcast- Sexuality and Orgasm Lauren Streicher MD, is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause, and a Senior Research Fellow of The Kinsey Institute, Indiana University. She is a certified menopause practitioner of The Menopause Society. She is the Medical Director of Community Education and Outreach for Midi Health. Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine. LINKS Subscribe To Dr. Streicher's Substack Information About the COME AGAIN Podcast Dr. Streicher's CV and additional bio information To Find a Menopause Clinician and Other Resources Glossary Of Medical Terminology Books by Lauren Streicher, MD Slip Sliding Away: Turning Back the Clock on Your Vagina-A gynecologist's guide to eliminating post-menopause dryness and pain Hot Flash Hell: A Gynecologist's Guide to Turning Down the Heat Sex Rx- Hormones, Health, and Your Best Sex Ever The Essential Guide to Hysterectomy Dr. Streicher's Inside Information podcast is for education and information and is not intended to replace medical advice from your personal healthcare clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast.
In this inspiring episode of SHE MD, hosts Mary Alice Haney and Dr. Thaïs Aliabadi welcome Dr. Mindy Goldman and Joanna Strober, founders of MIDI Health. Dr. Goldman shares her expertise on individualized hormone therapy approaches, while Strober explains how Midi Health is revolutionizing access to menopause care through telemedicine and more. The episode provides valuable insights for women navigating perimenopause and menopause, as well as healthcare professionals seeking to improve their understanding of hormone therapy. Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii. Sponsors: Purely Elizabeth: Visit purelyelizabeth.com and use code SHEMD at checkout for 20% off. Purely Elizabeth. Taste the Obsession.Timeline: Timeline is offering10% off your order of Mitopure. Go to timeline.com/SHEMD. Saks: Shop Saks.comCymbiotika: Go to Cymbiotikia.com/SHEMD for 20% off your order + free shipping today.David's Protein: David is giving my listeners an exclusive offer – buy four cartons and get the fifth free at davidprotein.com/shemdMIDI HEALTH'S KEY TAKEAWAYS:Evaluate Breast Cancer Risk: If you have a family history or genetic predisposition, consult with a specialist about hormone therapy and preventive measures.Consider Vaginal Estrogen: For vaginal dryness, vaginal estrogen can help, even if you have a history of breast cancer or a breast cancer patient.Assess Heart Health: Get a coronary calcium scan to evaluate heart health before starting hormone therapy. Consider Hormone Therapy Under The Age of 60: Discuss the potential benefits of bioidentical hormones with your doctor, 10 years before your menopause. The timing hypothesis says that the benefits of hormones tend to outweigh the risks if you start people within that 10-year window.Explore Non-Hormonal Alternatives: Lifestyle, dietary changes, and non-hormonal alternatives like CBT can help in managing menopausal symptomsIN THIS EPISODE: (00:00) Intro(01:27) How the Midi Health Founders got together and started Midi Health(06:50) HRT for Breast Cancer Patients(12:16) Hormones and breast cancer risk explained(24:55) How does Midi Health work?(33:16) Non-hormonal options for breast cancer patients(46:33) Can you use estrogen on your face?(48:18) When should you be on hormones and for how long?(57:51) Do you prefer estrogen patch or gel? (59:05) Testosterone, HRT, and menopause to improve libido(01:07:53) How to join Midi Health?RESOURCES:Visit MIDI Health website joinmidi.com: http://joinmidi.comJoanna Strober's LinkedIn: https://www.linkedin.com/company/midi-health/mycompany/Mindy Goldman's LinkedIn: https://www.linkedin.com/in/mindy-goldman-9b7a8930/GUEST BIOGRAPHY:Joanna Strober is the CEO and founder of Midi Health, a virtual care platform for women in perimenopause and menopause. The company brings expert care, covered by insurance, to women nationwide. Prior to Midi, Joanna founded Kurbo, the first digital therapeutic for childhood obesity, which was scaled to help tens of thousands children worldwide and the company was successfully sold to Weight Watchers in 2018. Prior to diving into digital health, Joanna spent more than 20 years in direct private equity and venture capital investing in health and consumer companies including a number of notable consumer internet companies, including BlueNile, eToys, Babycenter, HotJobs and Flycast.Joanna is the author of the book Getting to 50/50, a primer on how women can succeed and thrive at work and at home. She has spoken extensively to corporate and graduate school audiences on the topic of women and leadership. She was also named to the Forbes 50 over 50 list of top Innovators in 2023.Mindy Goldman is the Chief Clinical Officer at Midi Health and a Clinical Professor Emeritus in the Department of Obstetrics and Gynecology and Director of the Gynecology Center for Cancer Survivors and At-Risk Women Program at the University of California, San Francisco. As Midi's Chief Clinical Officer, Dr. Mindy Goldman brings her decades of experience as an OB/GYN to all our patient care, but survivors of breast cancer and at-risk women are a special focus for her. Dr. Goldman is a nationally recognized expert in the menopausal symptoms that come with treatment for breast cancer, and how to improve them safely and effectively. Dr. Goldman has created a unique program that bridges gynecology and breast oncology, and provides breast cancer survivors with care that is focused on quality of life and addresses specific women's health needs while undergoing cancer treatment. She is a nationally recognized expert in this field and in 2012 authored the American College of Gynecology (ACOG) Technical Bulletin that provides comprehensive clinical guidelines on the management of gynecologic issues in women with breast cancer. She is on the survivorship panel for the National Comprehensive Cancer Network (NCCN) and is the Sub-committee Chair for the panels on sexual functioning and menopause and helped author the NCCN management guidelines in these areas.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, I address the common questions I'm asked about the risk of urinary incontinence following surgery, specifically focusing on hysterectomy, prolapse repairs, and hip replacement. I discuss several key studies, including a 2000meta-analysis by Jeanette Brown and a 2023 paper in the American Journal of Obstetrics and Gynecology, which highlights the significant risks associated with these surgeries. I also provide tips on pelvic floor strengthening and the benefits of different surgical approaches to help minimize incontinence. I discuss how hip replacement surgery can have varying impacts on bladder function and the importance of a holistic view of the body's interconnectedness.https://pubmed.ncbi.nlm.nih.gov/10950229/https://www.nejm.org/doi/full/10.1056/NEJMoa054208https://pubmed.ncbi.nlm.nih.gov/24408744/https://pubmed.ncbi.nlm.nih.gov/36300551/Timeline:00:30 Introduction to Urinary Incontinence Risks00:59 Hysterectomy and Urinary Incontinence04:17 Prolapse Repairs and Bladder Leaking06:15 Hip Replacement and Bladder Function08:59 Conclusion and Key Takeaways
Joelle Taylor, MD, FACOG is a board-certified Reproductive Endocrinologist and a Diplomate of the American Board of Obstetrics and Gynecology. She is an active member of several leading scientific societies, including the American Society for Reproductive Medicine (ASRM), the Society of Reproductive Endocrinology and Infertility (SREI), the Society of Assisted Reproductive Technology (SART), and the American Congress of Obstetricians and Gynecologists (ACOG). Dr. Taylor earned her medical degree from the University at Buffalo School of Medicine and Biomedical Sciences in 2006. As a recipient of the Howard Hughes Medical Institute Scholar Award, she dedicated a year to research at the National Institutes of Health during her medical training. She went on to complete her residency in Obstetrics and Gynecology at Wake Forest University in 2010, followed by a fellowship in Reproductive Endocrinology and Infertility at the renowned Jones Institute for Reproductive Medicine in Norfolk, Virginia—home to the first IVF baby in the United States. Throughout her career, Dr. Taylor has been recognized with multiple research grants, has published extensively, and has presented her work at national conferences. Outside of her professional pursuits, Dr. Taylor lives in Jupiter with her family and their Australian Labradoodle. She enjoys weightlifting, yoga, playing pickleball, and cooking for family and friends.
In this episode we feature 2 articles that explore hot topics in genetics as well as opportunities to improve patient care in honor of DNA Day on April 25. DNA day commemorates the completion of the Human Genome Project and the discovery of DNA's double helix. Both of these studies utilize qualitative methodologies to highlight people's experiences and share their stories. Segment 1: Not Parent Expected” results through direct-to-consumer genetic testing Julia Becker (she/her) is a board-certified genetic counselor and CSU Stanislaus Genetic Counseling Program graduate. She has a strong interest in the ethical, psychological, and social implications of genetic testing, particularly in the context of unexpected parentage discoveries. Julia is the first author of the article, "Experiences of Individuals Receiving ‘Not Parent Expected' Results Through Direct-to-Consumer Genetic Testing," published in the Journal of Genetic Counseling. She presented this research at the American College of Medical Genetics and Genomics (ACMG) Annual Conference in 2021, contributing to the ongoing dialogue on the impact of unexpected genetic findings. Her work focuses on supporting individuals navigating complex genetic discoveries and advancing awareness within the genetic counseling community. In this segment we discuss: - The rise in Not Parent Expected (NPE) discoveries through direct-to-consumer genetic testing and what it means to receive this result. - Key emotional themes from interviews with 25 participants, including identity disruption, grief without death, and shifting family dynamics. - How a background in genetic counseling informed a sensitive and in-depth interview approach. - The emotional motivations behind seeking out biological relatives and the varied outcomes of those efforts. - The need for improved informed consent and follow-up care from DTC companies. Segment 2: Transgender and gender diverse patients' experiences with pregnancy-related genetics discussions: A qualitative study Jaime Schechner (she/her) works as a neurology genetic counselor at Boston Children's Hospital. She completed her Master of Science in Genetic Counseling at Boston University, and previously worked as a genetic counseling assistant at Beth Israel's Maternal Fetal Medicine Center. Darius Haghighat (he/him) is a reproductive genetic counselor at Boston Medical Center and an Assistant Professor of Obstetrics and Gynecology at Boston University Chobanian & Avedisian School of Medicine. He has prior experience as a cancer genetic counselor as well. He completed his Master's in Genetic Counseling at Boston University. As a queer genetic counselor he is especially passionate about LGBTQIA+ health equity. In this segment we discuss: - The inspiration behind focusing the study on pregnancy-related genetic counseling experiences among trans and gender diverse (TGD) individuals. - Major gaps in reproductive healthcare for TGD patients, including misgendering, binary language, and lack of provider knowledge. - Participant stories about feeling unseen or misgendered, and discussed the emotional impact of these encounters. - Frustrations with terms like "maternal" and "advanced maternal age," and suggested inclusive alternatives for clinical language. - Moments of affirming care, showing how small gestures can have a powerful impact across the healthcare journey. - The need for systemic change, including inclusive policies, provider education, and future research that centers TGD voices. Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors. Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”. For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others. Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com. DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Sydney Arlen.
Order my new book: Finally F**kn Fertile Using Yoga Meditation & Breathwork to Conceive! https://www.lisapinedayoga.com/store/p1/FINALLY_F%2ACKING_FERTILE_Using_Yoga%2C_Meditation_%26_Breathwork_to_Conceive.htmlDID YOU KNOW PCOS can be managed by some medications and even improve egg quality? In the latest episode of The Dismantling You Podcast I interview Dr. Cary Dicken Topics we discussed:*PCOS*Endometriosis*Egg Freezingand so much moreCary L. Dicken, MD, joined RMA of New York – Long Island in the fall of 2020. She comes to us from the Sher Institute for Reproductive Medicine in New York City, where she served as Associate Medical Director for over six years. Dr. Dicken is board certified in both Obstetrics & Gynecology and Reproductive Endocrinology & Infertility. She has been recognized by her peers and patients as an outstanding and compassionate physician. Dr. Dicken is a caring and warmhearted fertility specialist while still being honest and upfront with her patients. She is proud to be a reproductive endocrinologist and loves spending her days helping individuals/couples create the families they want.Contact Dr. Cary DickenWebsite: https://www.rmalongislandivf.com/physicians/cary-l-dicken-mdInstagram: @dr.cary.dicken
Surgeon and author Jeffrey A. Singer discusses his article "The FDA's outdated prescription rules are failing women and opioid users." He argues that the U.S. Food and Drug Administration's requirement for prescriptions for certain safe medications, specifically hormonal contraceptives and the opioid antidote naloxone, creates significant barriers to access and reflects outdated paternalism. Jeffrey highlights that obtaining prescriptions for birth control pills adds cost and inconvenience, disproportionately affecting women who report difficulty accessing appointments, despite decades of recommendations from major medical groups like the American College of Obstetrics and Gynecology and the American Medical Association for over-the-counter access, a standard in over 100 countries. He critiques the FDA's slow and partial move to allow only one type of progestin-only "mini-pill" over-the-counter, contrasting it with the easier access to emergency contraception. Similarly, Jeffrey discusses the years-long delay in making naloxone available over-the-counter, despite its proven safety, effectiveness by laypeople, availability in other countries, and requests from experts and even the FDA itself, noting how manufacturer financial incentives and state-level workarounds preceded the eventual, partial FDA approval for the nasal spray form. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
In this episode, we review the high-yield topic Menopause from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic Female Infertility from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic Reproductive Physiology from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic Adenomyosis from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic Mastitis from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic Primary Dysmenorrhea from the Gynecology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets